Cytosorbents Corporation is a medical technology company that focuses on developing innovative therapeutic solutions for critical care and cardiovascular patients

Their flagship product, CytoSorb, is a blood purification device designed to remove cytokines and other harmful substances from the bloodstream during severe illnesses, such as sepsis or acute respiratory distress syndrome. The company is dedicated to advancing treatment options that improve patient outcomes and reduce healthcare costs through its cutting-edge technology, which aims to enhance the management of life-threatening conditions in hospital settings.